1.1 How Medicine Became the Patient

During the nineteenth century, advances in physics, chemistry, and biology converged to form the basis for scientific medicine. Since then, medicine has achieved a historically unparalleled global dominance, grown into a global industry, and changed the previously pluralistic landscape of healing practices throughout the world. The expansion reached its zenith during the second half of the twentieth century, which historians and medical professionals often portray as the “golden age of medicine” (Porter Reference Porter2002; Kernahan Reference Kernahan2012; O’Mahony Reference O’Mahony2019a; Reference O’Mahony2019b),Footnote ¹ characterized by high levels of prestige and confidence in medical institutions and in the efficacy of medical interventions.

Whether such confidence is based on measurable therapeutic successes and contributions to longevity is, however, contested, and “revolutionary narratives” about advances sometimes interfere with more nuanced analyses (Farmer et al. Reference Farmer, Basilico, Messac, Greene, Condrau and Watkins2016). Already in the nineteenth century, pathologist Rudolf Virchow maintained that “the improvement of medicine may eventually prolong human life, but the improvement of social conditions can achieve this result more rapidly and more successfully” (quoted from DeWalt and Pincus Reference Dewalt and Pincus2003). A century later, physician Thomas McKeown argued that the reduction of mortality observed during the twentieth century is largely attributable not to medicine, but to better nutrition, housing, and public health measures (McKeown Reference McKeown1976).Footnote ² Writing in a time characterized by radical criticisms of societal institutions, McKeown’s work became part of a critical movement that advocated the reevaluation of medicine’s efficiency and societal role.

On the more radical side of this movement, some argued not only that sanitation, nutrition, and housing were more important determinants of health than medicine, but also that medicine has become an institution of social control (Zola Reference Zola1972) and a threat to health (Illich Reference Illich1974). Ivan Illich’s Reference Illich1974 paper “Medical Nemesis” in The Lancet, followed by his bestselling attack on modern medicine with the same title distinguished three types of iatrogenesis: clinical (i.e., direct harm by treatment), social (i.e., medicalization of life problems), and cultural (i.e., the loss of traditional ways of dealing with suffering). However, his radical indictment of medicine as “institutional hubris” (Illich Reference Illich1974, 922) and his calls for “deprofessionalisation of medicine” (Illich Reference Illich1974, 921) were dismissed by many medical professionals. His criticism was polemic, radical (i.e., maintaining that medicine probably did more harm than good), selective (e.g., downplaying successful aspects of medicine in relief and rehabilitation), driven by a more general criticism of modernity, and, importantly for our purposes, it came from outside of medicine.

Today, almost five decades after the publication of “Medical Nemesis,” medicine is increasingly subject to various forms of criticism that raise themes familiar from Illich’s work. The criticism is much more comprehensive, nuanced, and comes from inside medicine, that is, from leading medical professionals, which makes it harder to ignore. For example, in a publication in The Lancet (Reference O’Mahony2019a) and a book with the evocative title Can Medicine Be Cured? (Reference O’Mahony2019b), prominent gastroenterologist Seamus O’Mahony notes that since entering medicine toward the end of its “golden age,” he has witnessed decline and corruption in medical research and medical practice. He raises questions about three aspects of medicine.

First, O’Mahony maintains that “medical research … has itself become a patient,” increasingly scrutinized by metaresearchers. Second, he argues that “medicine has extended its dominion over nearly every aspect of human life,” herding “entire populations – through screening, awareness raising, disease mongering, and preventive prescribing – into patienthood” (O’Mahony Reference O’Mahony2019a, 1798–9; Reference O’Mahony2019b, 25–6). Third, he laments having witnessed “the public’s disenchantment with medicine,” as expressed in patient reports of their experiences in various health care settings. Patients have become, as O’Mahony (Reference O’Mahony2019b, 330) puts it, “a problem to be processed by the hospital’s conveyor belt; it is hardly surprising that they often feel that nobody seems to be in charge, or cares about them as individuals.”

The criticism by leading medical professionals like O’Mahony is worthy of further investigation, especially since the criticism and other challenges facing medicine (e.g., an aging population, explosion of costs) seem to indicate that medicine’s scope and role in society is fated to be altered in the twenty-first century. At this critical threshold, providing a firm grasp of dominant forms of criticism, explicating the norms they appeal to, and exploring the problems they draw attention to can assist an informed deliberation about the future of medicine.

To contribute to achieving this task, the chapter proceeds in three steps. First, it distinguishes three sorts of criticism that O’Mahony’s work touches on, but that can be found expressed in much greater detail elsewhere in the literature.Footnote ³ The criticism raises questions about medical research (skepticism), the use of medical means to address nonmedical problems (overmedicalization), and about features of medical care (objectification). Second, upon distinguishing forms of criticism and the nature of the norms they appeal to, it is argued that the criticism of medicine is social, internal, and appeals to constitutive norms of medicine. Third, it is argued that the criticism converges on more fundamental questions about (a) the aim of medicine, (b) the nature of medicine, and, less directly, (c) key concepts in medicine. Addressing these questions will not only help assess the criticism, but also contribute to a deliberation about the role of medicine in the twenty-first century.

1.2 Skepticism

When O’Mahony maintains that medical research “has become the patient,” he touches on a growing skepticism about whether the status and confidence that medicine has enjoyed in contemporary Western societies is justified. The roots of skepticism go back to the 1960s, when the prestige of the medical establishment suffered from catastrophic effects of new drugs,Footnote ⁴ as well as from the recognition that environmental hygiene, improved nutrition, and better living standards have contributed more than clinical medicine to guaranteeing longer lifespans.

In the contemporary landscape, we may distinguish two types of skepticism (see also Stegenga Reference Stegenga2018; Broadbent Reference Broadbent2019). Historical skepticism argues that mainstream medicine only merits its status since the emergence of modern clinical trials and since it acquired a genuine capacity to extend life during the mid-twentieth century.Footnote ⁵ Prior to this stage, despite all the progress in science, over the course of two thousand years medicine only achieved a few reasonably effective interventions (e.g., quinine for malaria, orange and lemon juice for scurvy, opium for pain relief, colchicum to treat gout, amyl nitrate to dilate arteries, herbal preparations as purgatives), and doctors knew that many of their interventions were ineffective (Porter Reference Porter1997; Reference Porter2002; Wootton Reference Wootton2006). Improvement had been achieved by discontinuing certain procedures (e.g., bloodletting) and introducing new procedures (e.g., hand washing), while other improvements (e.g., the retreat of diseases like diphtheria, typhoid, and tuberculosis) were attributable to better diet, housing, and working conditions. Even the striking victory against disease due to the introduction of a smallpox vaccination “came not through ‘science’ but through embracing popular medical folklore” (Porter Reference Porter1997, 11).

Worse, some argue that prior to the twentieth century, medicine might have done more harm than good, in part because it long held on to interventions based on humoral theory, which were ineffective or even detrimental to health.Footnote ⁶ For some two thousand years, alongside purging and vomiting, the principal therapy was bloodletting (phlebotomy or venesection), which weakened and sometimes even killed patients. Without the concept of infectious disease and persuaded that no two illnesses are identical, effectiveness could not be measured, and the commitment to this tradition often outweighed any contrary evidence.Footnote ⁷ The emergence of larger hospitals in the eighteenth century, often seen as a sign of great progress, in many cases actually made medicine more dangerous. For example, while mothers and infants had previously been relatively safe in the care of informally trained midwives, nineteenth-century hospitals significantly increased the risk of death, because doctors inadvertently spread infections from one patient to the other on their instruments and hands.

Contemporary skepticism draws attention to present-day challenges and is promoted by some prominent and respected physicians and epidemiologists. In the extremely influential article “Why Most Published Research Findings Are False,” published in the journal PLoS Medicine, John P. A. Ioannidis explored the reliability of published medical research findings and concluded that the majority of published research claims are false (Ioannidis Reference Ioannidis2005; see also Reference Ioannidis2016).Footnote ⁸ In similar ways, prompted in part by escalating health care costs and the growing preparedness to render medicine more evidence based, a growing amount of meta-research casts doubt on the efficacy of some widely used treatments, identifying factors that can influence the choice of topic, study design, and methodology in ways that potentially undermine the validity of published research findings. Building on this line of research, Jacob Stegenga (Reference Stegenga2018) argues that it is difficult to vindicate our confidence in the efficiency of contemporary treatments to eliminate the symptoms and underlying causes of disease. In fact, Stegenga (Reference Stegenga2018, 11) concludes that except for a few “magic bullets,” we ought to have low confidence in the effectiveness of interventions.

Stegenga (Reference Stegenga2018) formulates the argument by using Bayes’s Theorem, which calculates the probability of a hypothesis (H) provided evidence (E) that appears to support H. The probability of H given E, P(H|E), depends on three other probabilities: (i) the prior probability of H being true, regardless of E (i.e., P(H)); (ii) the probability of the evidence given H (i.e., P(E|H)); and (iii) the prior probability of E, irrespective of H (i.e., P(E)). The resulting equation, P(H|E) = P(H) × P(E|H) / P(E)*, states that the probability of H given E is equal to the prior probability of H, multiplied by the probability of E given the hypothesis, divided by the prior probability of E.Footnote ⁹

How does this support the skeptical thesis that we ought to have low confidence in the effectiveness of interventions? For P(H|E) to be low (i.e., the posterior probability of the medical intervention is effective, given evidence that appears to support its effectiveness) three conditions have to be met.

1. (1)

   P(H) is low (i.e., the prior probability that a particular medical intervention is effective is low).

1. (2)

   P(E|H) is low (i.e., the evidence observed is improbable given the hypothesis that the intervention is effective).

1. (3)

   P(E) is high (i.e., the prior probability of observing evidence that supports the intervention is high, regardless of whether it is actually effective).

Stegenga offers support for the thesis that these three conditions are met in current research, and the main points may be summarized as follows. In support of (1), one can give an inductive argument from the fact that most of the medical interventions tested prove unsuccessful. Drug companies test a large number of interventions that fail and never make it to the market. But even among those that pass the tests and reach the consumer, a significant number are later restricted or entirely withdrawn.Footnote ¹⁰ It is certainly possible that highly successful “magic bullets” (e.g., antibiotics, vaccines, insulin for diabetic treatment) that target a highly specific cause of disease in an effective manner (without many side effects) will be discovered. But there are reasons to remain skeptical about the chances of such discoveries. First, magic bullets are “low-hanging fruit,” which means that most of them have probably been discovered already. Second, it is very difficult to devise an intervention that is both highly specific and effectively targets diseases with complex and poorly understood underlying causal mechanisms. The current tools for intervening, like various forms of chemotherapy, are often rather crude and nonspecific.

In support of (2), Stegenga stresses that in many cases interventions are little better than placebo, that effect sizes in trials tend to be low, and that studies frequently reach discordant results (Stegenga Reference Stegenga2018, 171–5). Good examples of particularly low effect sizes in widely prescribed medications include antidepressants and cholesterol-lowering drugs (statins). The best available evidence suggests that they have minimal positive effects. While selective serotonin reuptake inhibitors (SSRIs) only do slightly better than a placebo at managing depression (Kirsch Reference Kirsch2019), statins lower cholesterol levels, but fail to clearly decrease mortality in asymptomatic patients: in order to avoid a single death from any cause, physicians have to prescribe them to about 244 people with no history of heart disease for five years (see Redberg and Katz Reference Redberg and Katz2016). Moreover, the evidence for effectiveness is uncertain in many cases, with some studies suggesting positive effects, while others suggesting no effects or negative effects.

In support of (3), it is to be expected to find evidence indicating that an intervention is effective even if it is not, in part because the institutional structure of medical research is biased in favor of positive evidence. Evidential standards (e.g., meta-analyses and systematic reviews, hierarchy of evidence, randomized controlled trials) do not eliminate problems with the malleability of research methods. Meta-analysis involves subjective judgments about inclusion criteria, the weight given to studies, and the correct interpretation of the results, such that two groups of researchers analyzing the same evidence can report different conclusions. The inter-rater and inter-tool reliability for assessing the quality of evidence is not very high, which means that such studies may not be able to effectively identify biases. In addition, the structure of medical science might incentivize exploiting the malleability of the methods to produce evidence of positive effects, especially in cases in which trials are conducted by the companies who manufacture the products being tested. Potentially aggravating problems of malleability, pharmaceutical companies and scientists have a vested interest in reporting positive effects, while there is a bias against reporting negative findings and no incentive to replicate findings.Footnote ¹¹

Overall, bearing in mind the factors that support (1)–(3), the limitations of professional standards (e.g., peer reviewers can evaluate the quality of the submitted studies, but these might consist of a biased sample of the total evidence), and the limits of regulatory oversight, the upshot is this: even after taking into account seemingly solid evidence in favor of the effectiveness of an intervention, we ought still to assign only a low probability to the claim that it is effective. The skeptical conclusion in Stegenga’s work is based on an inference to the best explanation that uses numerous examples and is supported by the identification of methodological, social, and financial factors. It is consistent with the fact that we generally underestimate the role of nonmedical interventions like changes in hygiene and nutrition in improving health and the role of medicine in adverse health outcomes.Footnote ¹² Accepting the conclusion does not require denying the possibility of genuine medical breakthroughs (e.g., genetic engineering leading to highly effective interventions), but it supports a skeptical attitude toward claims about them. One important limitation that we will return to in Chapter 8 is that the assessment of the effectiveness of medical interventions is based on a narrow notion of what constitutes “medical,” construed essentially as using pharmaceuticals to target diseases.

1.3 Overmedicalization

The second issue that O’Mahony mentions is linked to the fact that, parallel to the ascent in the standing of the medical profession, a growing number of issues and conditions came to be portrayed and comprehended in medical terms, including pregnancy, obesity, alcoholism, lack of success in education, and drug addiction. During the 1970s, the term “medicalization” was coined to describe such processes by which conditions previously considered as nonmedical are increasingly defined and treated as medical problems (typically as illness, disorder, or disease) and handled by medical professionals. For example, saying that pregnancy has been medicalized means that pregnancy is now seen as a potential disruption to health that requires expert medical care and risk management.

As such, medicalization is a value neutral, descriptive term designating cases in which medical means are used for conditions hitherto considered as outside the medical realm. For instance, medicalization occurred when a set of problems known as shell shock was redescribed as the symptoms of the medical condition post-traumatic stress disorder (PTSD), or when alcoholism was transformed from a moral to a primarily medical problem. The identification of a previously overlooked disease can also be seen as the result of medicalization, and so can efficient birth control (Parens Reference Parens2013).

In contrast, overmedicalization involves the improper use of medical resources. Of course, improper use as such is not sufficient for overmedicalization: physicians assisting in torture arguably put to use medical resources in an improper fashion without being involved in overmedicalization. Instead, overmedicalization refers to the improper use of medical resources to address political, social, and personal problems, often replacing established practices that traditionally addressed them. It can occur in two ways. A condition can be medicalized with or without pathologization, that is, attaining the label of a pathological condition (Sholl Reference Sholl2017). Overmedicalization that does not involve pathologization describes a change toward comprehending various types of medical interventions as justified with respect to a condition. Critics typically speak about overmedicalization in this sense with respect to pregnancy, fertility, and death. Overmedicalization that involves pathologization describes how certain conditions that enter the medical jurisdiction become labelled as pathological (e.g., alcoholism, epilepsy). Critics typically argue that a category error occurs that turns life problems and normal human variations into pathological conditions (Parens Reference Parens2013). For example, while individuals living in social isolation due to being severely shy and socially awkward were traditionally not considered as suffering from a medical condition, they are today increasingly diagnosed with mental disorders like social phobia or social anxiety disorder, which imply some difference in kind from “normal shyness.”

Critics argue that overmedicalization has a number of potentially severe consequences. First, by expanding the category of what demands medical action, overmedicalization increases the number of people deemed to be in need of medical intervention by many millions and contributes to the explosion of the costs of medical treatment. In the case of social phobia or social anxiety disorder, at any given time, almost 5 percent of the US population meets the diagnostic criteria. For some, this shows that overmedicalization is driven by medical industries that stand to earn massive profits by classifying as pathological conditions that were previously perceived as variations of normal states.Footnote ¹³ Such practices of “disease-mongering” aim to increase the number of people who can be diagnosed by relaxing diagnostic criteria, by constructing more or less bogus disease categories, or by transforming risk factors or precursors to disease into diseases. For example, the decision to lower the diagnostic threshold for high cholesterol was surrounded by controversy, not merely for clinical reasons, but also because the vast majority of the experts on the panel that revised the relevant guidelines had financial ties to pharmaceutical companies that manufactured cholesterol-lowering drugs (Moynihan and Cassels Reference Moynihan and Cassels2005).

Some of the structural characteristics of regulating the industry offer financial incentives for disease-mongering. For example, a company can hold on to the protection of a patent in case a new use for the product is developed. Eli Lilly supported defining a new disease called premenstrual dysphoric disorder (PMDD), rebranded fluoxetine as Sarafem, and received FDA approval for promoting Sarafem for PMDD. This secured the extension of their patent on fluoxetine, at a time when many disagreed that PMDD was a genuine disease. The FDA approval in fact came before the APA decided to recognize PMDD as a distinct psychiatric condition (see, e.g., Mintzes Reference Mintzes2006).

Second, the worry is that overmedicalization in some cases does not reflect clinical observations or findings, but predominantly social judgments about what is considered to be appropriate behavior (Scott Reference Scott2006; Conrad Reference Conrad2007). More precisely, overmedicalization might be taken to reflect disapprobation of behavior that is perceived as failing to conform to dominant values in contemporary culture. In the case of shyness, the relevant dominant values are those attached to being self-confident, talkative, assertive, and comfortable with self-presentation.

Third, overmedicalization changes the focus of problem-solving to individual-level medical interventions and away from the political and social structures that generate conditions under which being severely shy is increasingly a debilitating problem. This obstructs the emergence of genuine public deliberation that might lead to rethinking whether the relevant dominant values in contemporary culture – such as the value of capacity to perform with ease in the social realm – should be resisted. Such deliberation might lead us to revise entrenched ideas about the acceptable norms of navigating social situations in a way that would allow recognizing a larger natural variation in social skills and behavior.

Fourth, overmedicalization appears to be causally implicated in an increase in the number of healthy people who are seriously concerned about their health. In a development that seems puzzling in light of gains in lifespan and health, people increasingly see their lives as acutely threatened by real but trivial risks or sometimes by downright fictional hazards (e.g., cell phones, low radiation) (Le Fanu Reference Le Fanu2012). It is highly probable that the explosion of conditions and risk factors that are now classified as pathological has contributed to this development.

Fifth, overmedicalization may lead to overdiagnosis and overtreatment, for example, in cases in which physicians accurately diagnose a patient as having the pathophysiological basis P of a disease D, where P would never have led to symptoms of disease D and would not have interfered with the patient’s life. This case becomes one of overtreatment if the patient in question is treated for D by intervening on P. Overtreatment in this case does not directly result from lowering the thresholds for D, but from deploying more precise ways of detection in very early stages. For example, some argue that screening programs for prostate cancer lead to overdiagnosis and overtreatment (Loeb et al. Reference Loeb, Bjurlin and Nicholson2014). The point is that a large number of patients diagnosed with prostate cancer might receive unnecessary treatment, as they would not develop symptoms if left untreated.

1.4 Objectification

Finally, O’Mahony identifies a different and growing problem with respect to medical care. Dissatisfaction with mainstream medicine among patients as well as practitioners has grown during the last decades, amplified by the implementation of new managerial strategies and cost-capping initiatives (in welfare states) and by growing suspicion that medicine is excessively driven by profit (e.g., in the US). Critics argue that mainstream medicine fails to offer empathetic care driven by patient need. Patients seek not only scientifically based management of their conditions, but also what is often described as a “humane” care that also addresses the existential or psychological aspects of those ailments. They want to be relieved and cured, but they also seek explanations of their predicaments, a sense of wholeness, and control (Porter Reference Porter1997, 51). Patients increasingly complain that such needs are not met and that the care they receive is often “objectified” or “dehumanized.” Without being able to do justice to the full complexity of the phenomenon, some clarification can be achieved by briefly examining factors like technological mediation and deindividualization in health care environments that critics link to objectification.

First, the advances in therapeutic and diagnostic devices have contributed to the emergence of technologically mediated management that suppresses dimensions of care that would address the psychological and social dimensions of ailments (Blumer and Meyer Reference Blumer and Meyer2006; Marcum Reference Marcum and Marcum2012). The emphasis on this type of management and its increased dependence on sophisticated technology stimulates the tendency to sideline the patient’s illness experience from the clinical consultation. It predisposes physicians toward perceiving the body of the patient as a system constituted by cooperating and separately operating parts, and such a focus contributes to perceiving the patient’s individuality, subjective experience, and personal narrative as something that risks obfuscating direct access to the disease. The patient as a person is at risk of disappearing in the encounter, eroding the conditions for an intimate relationship with a medical professional that many patients associate with earlier stages of medical practice. Critics argue that with this development, medicine has lost something crucial. As Cassell (Reference Cassell2004, ii) puts it, medical doctors are now “less skilled at what were once thought to be the basic skills of doctors – discovering the history of an illness through questioning and physical examination, and working toward healing the whole person” (see also Weatherall Reference Weatherall1996, 17).

Second, health care environments tend to deindividualize both patients and physicians, which probably contributes to the experience of receiving objectifying care, sometimes also described as “dehumanizing.” In a mutually reinforcing process, the deindividualized appearance of the patients (e.g., wearing uniform coats and gowns) might make them appear less as individual agents that require empathy, while the deindividualized appearance of the physicians (e.g., wearing uniform white coats) might mask their individual responsibility toward patients. The nature of these environments might also contribute to practices that increase objectification. For example, patients are sometimes labeled in terms of their illnesses (“diabetic” instead of “a person with diabetes”) or referred to by acronyms or by the body part being operatively intervened on, both of which collapse the distance between the person and the disease (see, e.g., Haslam et al. Reference Haslam, Loughnan, Reynolds and Wilson2007; Todres, Galvin, and Holloway Reference Todres, Galvin and Holloway2009; Haque and Waytz Reference Haque and Waytz2012). Such practices increase the likelihood of medical professionals forgetting that they are engaged with people who are in vulnerable states, who grant them access to highly private aspects of their life, and whose trust they need in order to be able to care for them (Engelhardt and Jotterand Reference Engelhardt and Jotterand2008). Highly specialized health care that focuses entirely on the disease often translates illness experiences into several different diagnoses in a way that does not render their predicament transparent and meaningful to the patient, leading to experiences of objectification. As a patient puts it, “you do not feel human, but … as an object on a conveyor belt, no one really cares. They have decided, medical science has determined, that’s the way it is” (Berglund et al. Reference Berglund, Westin, Svanström and Sundler2012). Such reproaches do not target human error in the work of physicians or nurses, but systemic problems and institutional culture.

Of course, voicing these concerns does not require denial of the numerous benefits associated with using technologically sophisticated devices or the benefits of focusing more narrowly on less than the whole human being in diagnosis and intervention.Footnote ¹⁴ For example, pharmacological treatments of mental disorders may necessitate switching from the language of subjective symptoms to that of biochemical processes, even if it may lead to patients feeling objectified. Also, in certain scenarios, there might be some benefits associated with not focusing on the patient as a fully social being. The training of physicians encourages effective regulation of empathy, which dampens emotional responses that result from perceiving others suffering and can help physicians deal with stress (Di Bernardo et al. Reference Di Bernardo, Visintin, Dazzi and Capozza2011). Many medical procedures involve inflicting pain on the patient, and it is likely that such procedures could be efficient without significantly reducing the distress that comes with causing pain.

The experience of unmet needs during medical care may be one of the reasons for the growing popularity and prominence of “complementary and alternative medicine” (CAM). This describes a broad range of health practices that historically originate outside of conventional or mainstream medicine (e.g., acupuncture, herbal remedies, naturopathy, homeopathy, and chiropractic), which position themselves in relation to mainstream medicine, but differ in their attitude to it. In spite of efforts by medical authorities to keep in check the proliferation of CAM services and products, the National Health Interview Survey from 2007 reveals about 40 percent of US residents use at least one CAM health practice, and the number of visits to providers of CAM outnumbers the visits to primary care physicians practicing mainstream medicine (Barnes, Bloom, and Nahin Reference Barnes, Bloom and Nahin2007).

While this popularity is in part explained by increased economic wealth that stimulates the consumption of “health products” (e.g., vitamins, plant extracts, etc.), it is also linked to the perception of mainstream medicine as objectifying, and sometimes also authoritative and bureaucratic. Although the motives are not entirely clear, what patients describe as a lack of bedside manner and an objectifying environment in mainstream medicine is one of the reasons for the popularity of alternative medicine (Astin Reference Astin1998). As Bivins (Reference Bivins2010, 36–7) puts it, “the rigors of biomedicine from the patients’ perspective – the degree to which it was impersonal, driven by and constructed around the needs of the laboratory and technology …, and disease- rather than patient-focused – provoked many to accuse both the medical system and its practitioners of arrogance, insensitivity, and greed.” Along such lines, some movements entirely reject mainstream medicine and denounce it as a part of an elitist “conspiracy against the laity” (Porter Reference Porter2002, 45).

1.5 The Character of the Criticism

Taken together, the three forms of criticism are comprehensive and highlight substantial challenges: medicine is scientifically less rigorous and trustworthy than generally thought (skepticism), medical resources are improperly used to address nonmedical problems (overmedicalization), and the care received violates expectations (objectification). The criticism thus targets medicine as both a medical science and a medical practice, and it constitutes a powerful assembly of forces that will contribute to transforming medicine in the twenty-first century. At the same time, the criticism is nuanced in the sense that it simultaneously recognizes that medicine is facing different challenges than just a century ago. Critics are well aware that increased longevity due to advances brings to the fore a range of chronic diseases that are much more difficult to treat. Also, they are aware that medical professionals increasingly encounter individuals with composite medical and social needs (e.g., related to homelessness and substance abuse), and it would be unrealistic to expect that professionals with medically defined roles would be able to meet these needs.

The following sections further explicate the criticism and the challenges to medicine it highlights. One important step toward completing this task is to unearth the specific normative character that the different forms of criticism share. Focusing on the nature of the standards of evaluation that they deploy can assist a better understanding of the criticism but also provide clues as to how to deal with the challenges to which they point. Before we start, two notes on the choice of terms are in order.

First, a note on what “criticism” means. In this case, as well as in general, criticism aims to raise awareness of a problem and contribute to changing the state of the target, which can be some state of affairs in the world, or (e.g., historical skepticism) the stance that we take toward it. Importantly, while change can be effectuated in a number of ways (e.g., using monetary incentives, threats, manipulation), criticism aims to change things by offering reasons. For this, besides appealing to certain observed facts, it has to appeal to some norm that purports to provide a reason and thereby justify change (Kauppinen Reference Kauppinen2002). Norms specify standards that can be met or fail to be met; they prohibit and permit courses of action, but they also implicitly structure the space of possibilities of action (Jaeggi Reference Jaeggi2018, ch. 3). Norms are linked to values, on the one hand (e.g., courage is a general value, norms define what is courageous behavior in a situation), and to reasons, on the other. A justification can be suitably demanded for why norms should be met, but in many cases they are profoundly implicit, such that it would not make sense to demand one.Footnote ¹⁵

Second, some distinguish between “criticism” and “critique” and take the former to refer to something less elaborated and directed toward persons and the latter to be a more developed consideration upon a subject. However, this distinction is ambiguous and not used systematically in the literature. For example, in his discussion of criticism in science and philosophy, Popper (Reference Popper2000) consistently speaks of “criticism,” even though the way he uses the term fits the definition of “critique.” For this reason, we will use “criticism” in a broad sense, which includes instances of “critique.”

1.6 The Use of the Criticism

Useful criticism tends to illuminate its subject, and metacriticism that systematically considers different strands of criticism can offer further contributions in this regard. We have so far been able to show that we are predominantly dealing with instances of internal criticism that appeal to constitutive norms of medicine, many of which are implicit. In general, implicit norms can be hard to identify, as we often first become conscious of their existence when they are violated. By conveying the perception of norm violations, the criticism makes important steps toward making more or less implicit norms explicit, which enables subjecting them to rational scrutiny. Moreover, we have also seen that the criticism appeals to two kind of norms. The skeptic’s criticism appeals to epistemic norms of science, the criticism of overmedicalization appeals to norms governing medical knowledge that forbid certain uses, and the criticism of objectification appeals to moral norms that forbid a certain way of treating patients, even if their diseases are successfully removed. In the latter case, the criticism is informative in an additional way, because it shows that norm violation gives rise to “reactive attitudes” (e.g., indignation). Such reactive attitudes are best explained by positing the presence of implicit moral norms that are perceived to be violated.

These findings offer us a better view of the normative sources of the criticism, but they also help us comprehend that the criticism converges on more fundamental questions about (a) the aim of medicine, (b) the nature of medicine, and (c) the key concepts of health and disease, which correspond to the three levels of analysis of the normative approach that will be introduced in Chapter 2. With respect to (a), when critics like O’Mahony call on medicine to change its course and charge that it has overextended its dominion, this is based on a persuasion that medicine is currently not advancing toward its true aim. The criticisms of overmedicalization and objectification both point in this direction, maintaining that medicine has deviated from its course.Footnote ²⁰ Moreover, the implicit assumptions of different strands are conflicting: the charge of overmedicalization seems to assume that (i) the aim of medicine is the removal and prevention of disease, while the charge of objectification seems to assume that (ii) the aim of medicine is to enhance well-being in a wider sense. If it turns out that (i) is true, then much of the charge of objectification looks unreasonable. After all, the successful removal and prevention of disease does not necessitate eliminating the features that critics of objectification draw attention to. In contrast, if (ii) is true, then the charge of overmedicalization begins to look mysterious.

With respect to (b), the skeptical criticism of medicine as science claims that current research practices are not consistent with the (scientific) nature of medicine. But Stegenga’s skeptical thesis also has implications for questions about (a). This is due to the fact that although some of the arguments could be extended to domains of medicine, his thesis focuses on one kind of therapeutic intervention, namely intervention using pharmaceuticals. It does not systematically consider other types of standard interventions (e.g., surgical interventions, interventions in the form of radiation therapy or physical therapies, nonpharmaceutical rehabilitation procedures, lifestyle interventions). Moreover, in order for a medical intervention to qualify as effective, Stegenga’s framework requires that it must target the constitutive causal basis of a disease, the harms caused by the disease, or both (Stegenga Reference Stegenga2018, 15). This means that interventions that target conditions that are not “genuine diseases” (e.g., interventions on predisease states or on inappropriately medicalized conditions) are excluded. In addition, interventions in the form of vaccination are excluded because they aim to prevent the transmission of diseases rather than treat diseases (Reference Stegenga2018, 179), while a large number of other interventions (e.g., contraception, abortion, relieving teething pain, or menstrual cramps) are excluded because they do not target the constitutive causal basis of a disease or the harms caused by it.

Anticipating the objection that his view builds on an overly narrow account of the goal of medicine, Stegenga (Reference Stegenga2018, 52–3) grants “the multifaceted goals of medicine and the plural activities of physicians,” but stresses that his analysis applies to one goal in medicine, which is the improvement of health by intervening on disease. While this seems like a suitable reply to the objection, we may note that the consequences of the skeptical thesis for an overall assessment of medicine will depend on what the overall or final aim of medicine is and on how the goal to which Stegenga’s analysis applies is related to it. For instance, the consequences of accepting the skeptical conclusion with respect to an overall assessment of medicine will be very different if one sides with critics of overmedicalization (i.e., the aim of medicine is the removal and prevention of disease) or if one sides with critics of objectification (i.e., the aim of medicine is to enhance well-being in a wider sense). In fact, critics of objectification could accept the skeptical conclusion while still holding on to the view that medicine as a whole is successful and produces significant progress.

Finally, with respect to (c), the charges of overmedicalization and objectification also implicate the notions of health and disease and claim that these have been altered to fit objectives that do not align with the aim of medicine. To assess whether such a claim is justified will likely require careful explication of the concepts of health and disease in light of the question about the aim of medicine.

Overall, there is therefore support for thinking that the criticism converges on such fundamental questions that correspond to the three levels of analysis of the normative approach. However, while these assumptions offer a normative backdrop for much of the criticism, critics do not offer systematic defenses of them. But, without this, the scope and significance of the criticism are limited. To better comprehend the criticism and to assess whether it is justified, the additional step of clarifying these fundamental issues seems indispensable. At the same time, attaining clarity about these issues makes a further inquiry worthwhile for additional reasons.

First, criticism that illuminates its subject can offer clues to the solution of the problem that it points to. However, taking further steps toward a solution would be greatly facilitated by an accurate account of the nature of the problem, which requires discerning the aim of the practice criticized. Without it, it is not clear what kinds of solutions are suitable with respect to the norm violations that propel the criticism. For example, by making a connection between aim and norms, one can discern whether the purported norm violation is an expression of a local problem (e.g., the norms of a practice no longer promote its aim) or a systemic problem (e.g., the norms of the practice are inconsistent). In the former case, problems typically have internal solutions, while in the latter they might resist a resolution within the current constellation.

Second, the emergence of the criticism is in part an expression of a new uncertainty about the proper role and scope of medicine in modern societies. Therefore, answering questions about the aim of medicine will not only help address the challenges that the criticism raises (i.e., determining the scientific nature of medicine, its proper boundaries, and the appropriate use of medical means), but it will also provide impulses to redefining medicine’s role in society in the twentieth century. In this regard, consistent with the normative approach, it is important to stress that seeking to discover what the aim of medicine is should not be viewed as a separate undertaking from seeking to answer the question of what it ought to be.

Having offered reasons for why completing this additional step would be valuable, we may close by adding that the criticism also points toward how the question about the aim of medicine is to be answered. Taking seriously all three strands of criticism, one could argue that even if medicine suddenly became much more successful in curing and treating diseases (thus defeating the skeptical criticism), that would not resolve the criticisms of overmedicalization and objectification. And if the latter criticisms implicate questions about the aim of medicine, then we might start suspecting that there is more to medicine’s aim than curing and preventing diseases. We will return to this issue in Chapter 6.

1.7 Conclusion

This chapter directed its focus at dominant forms of criticism, attempting to offer a better comprehension of their normative character and the challenges they convey. It was argued that the criticism is comprehensive (i.e., raises questions about both medical science and medical practice), mainly internal (i.e., relies on standards of evaluation that are assumed to be internal to medicine), and converges on a larger question about (a) the aim of medicine, (b) the nature of medicine, and (c) key concepts in medicine.

The criticism unearths challenges to medicine that require us to address basic questions on all of these three levels. Directing attention to these basic issues will not only help clarify to what extent the criticism is justified, but also assist an informed deliberation about the future of medicine. The main aim of the following chapters is to undertake this task. While Chapters 4 and 6 are chiefly dedicated to (a) and (c), Chapter 3 starts by addressing (b), and thus the question about the (scientific) nature of medicine. But, before that, Chapter 2 presents a particular, normative approach to philosophy of medicine that guides the inquiry in this book. It will be shown how this approach and the three levels of analysis it emphasizes can contribute to addressing the current challenges.